Higher hemoglobin target with epoetin alfa is hrmful in chronic kidney disease

被引：0
|
作者：
Singh, A. K.
Szczech, L.
Tang, K. L.
机构：
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2007年 / 74卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] Hemoglobin Variability With Extended Dosing of Epoetin Alfa in Patients With Chronic Kidney Disease and Not on Dialysis
    Bailey, Robert A.
    McGowan, Tracy
    Tang, K. Linda
    Langholff, Wayne K.
    Lantz, Keith C.
    Wolfson, Marsha
    DIALYSIS & TRANSPLANTATION, 2009, 38 (10) : 407 - +
  • [2] The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease
    Cremieux, Pierre-Yves
    Van Audenrode, Marc
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (12) : 2329 - 2336
  • [3] Correction of anemia with epoetin alfa in chronic kidney disease
    Singh, Ajay K.
    Szczech, Lynda
    Tang, Kezhen L.
    Barnhart, Huiman
    Sapp, Shelly
    Wolfson, Marsha
    Reddan, Donal
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2085 - 2098
  • [4] Comment on:: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease
    Einarson, Thomas
    Machado, Marcio
    Walker, John
    Iskedjian, Michael
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (07) : 1571 - 1573
  • [5] Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
    Lefebvre, Patrick
    Vekeman, Francis
    Sarokhan, Brenda
    Enny, Christopher
    Provenzano, Robert
    Cremieux, Pierre-Yves
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) : 1929 - 1937
  • [6] Hemoglobin and hematocrit response for alternate dosing strategies of epoetin alfa in pre-dialysis chronic kidney disease
    Sarac, E
    Smavatkul, C
    Boolchand, V
    Gemmel, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : A41 - A41
  • [7] Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease
    Chen, Han-Hsiang
    Tarng, Der-Cherng
    Lee, Kun-Feng
    Wu, Chih-Jen
    Chen, Yi-Chou
    JOURNAL OF NEPHROLOGY, 2008, 21 (04) : 543 - 549
  • [8] Comment on:: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease -: Reply
    Cremieux, Pierre-Yves
    Van Audenrode, Marc
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (07) : 1573 - 1574
  • [9] Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study
    Nurko, Saul
    Spirko, Rita
    Law, Amy
    Dennis, Vincent W.
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 2010 - 2021
  • [10] Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease
    McCullough, Peter A.
    Barnhart, Huiman X.
    Inrig, Jula K.
    Reddan, Donal
    Sapp, Shelly
    Patel, Uptal D.
    Singh, Ajay K.
    Szczech, Lynda A.
    Califf, Robert M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2013, 37 (06) : 549 - 558
12345